KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Depreciation and Depletion (2016 - 2025)

Charles River Laboratories International has reported Depreciation and Depletion over the past 15 years, most recently at $45.1 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 6.82% year-over-year to $45.1 million; the TTM value through Dec 2025 reached $177.6 million, down 6.62%, while the annual FY2025 figure was $177.6 million, 6.62% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $45.1 million at Charles River Laboratories International, up from $44.8 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $155.6 million in Q4 2022 and troughed at $559000.0 in Q1 2022.
  • A 5-year average of $42.1 million and a median of $44.4 million in 2023 define the central range for Depreciation and Depletion.
  • On a YoY basis, Depreciation and Depletion climbed as much as 7878.53% in 2023 and fell as far as 70.12% in 2023.
  • Year by year, Depreciation and Depletion stood at $138.6 million in 2021, then grew by 12.28% to $155.6 million in 2022, then plummeted by 70.12% to $46.5 million in 2023, then increased by 4.09% to $48.4 million in 2024, then decreased by 6.82% to $45.1 million in 2025.
  • Business Quant data shows Depreciation and Depletion for CRL at $45.1 million in Q4 2025, $44.8 million in Q3 2025, and $44.3 million in Q2 2025.